Trial of Pembrolizumab and Radiotherapy in Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
- Status
- COMPLETED
- Phase
- PHASE2
A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- NA
Digital vs. Printed Photographs: Impact on Skin Self-Examinations
- Status
- COMPLETED
- Phase
- NA
A Phase 1 Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Subjects With Select Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of a Helper Peptide Vaccine Plus Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Application of Genomic Techniques and Image Processing Using Artificial Intelligence to Obtain a Predictor Model Risk of Melanoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
- Status
- COMPLETED
- Phase
- PHASE2
Videoscopic Ilioinguinal Lymphadenectomy for Melanoma
- Status
- COMPLETED
- Phase
- NA
SPECTAmel: Screening Patients With Melanoma Tumors for Efficient Clinical Trial Access
- Status
- WITHDRAWN
- Phase
- N/A
Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Cytokine-induced Killer Study for Patients With Stage II Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trial of pIL-12/MK-3475 in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of the CD40 Agonistic Monoclonal Antibody APX005M
- Status
- COMPLETED
- Phase
- PHASE1